Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Mayer

Showing results (121-130 of 243) with videos related to

Pageof 25
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2015
Diabetes-related end-stage renal disease in Austria 1965-2013Friedrich C Prischl, Martin Auinger, Marcus Säemann, et al.
Nephron. Experimental Nephrology|February 28, 2004
Role of thrombospondin-1 in the autologous phase of an accelerated model of anti-glomerular basement membrane glomerulonephritisKathrin Hochegger, Sara Knight, Christian Hugo, et al.
International Journal of Molecular Sciences|November 3, 2020
Empagliflozin Inhibits Basal and IL-1β-Mediated MCP-1/CCL2 and Endothelin-1 Expression in Human Proximal Tubular CellsMarkus Pirklbauer, Maximilian Bernd, Lisa Fuchs, et al.
International Journal of Molecular Sciences|July 2, 2021
Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney DiseaseJohannes Leierer, Paul Perco, Benedikt Hofer, et al.
European Journal of Clinical Investigation|December 20, 2024
Type 2 diabetes and chronic kidney disease as long-term predictors of cardiovascular events in patients with coronary artery diseaseLaura Schnetzer, Andreas Leiherer, Andreas Festa, et al.
Pediatric Nephrology (Berlin, Germany)|March 11, 2016
The nephrologist of tomorrow: towards a kidney-omic futureMina H Hanna, Alessandra Dalla Gassa, Gert Mayer, et al.
Diabetologia|April 20, 2019
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney diseaseHiddo J L Heerspink, Paul Perco, Skander Mulder, et al.
Immunology|January 25, 2007
Expression of granzyme A in human polymorphonuclear neutrophilsKathrin Hochegger, Philipp Eller, Julia M Huber, et al.
International Journal of Clinical and Experimental Pathology|September 10, 2011
The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomeru-lonephritisEmanuel Zitt, Kathrin Eller, Julia M Huber, et al.
Medicine|December 5, 2014
Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case reportAndreas Kronbichler, Renate Frank, Michael Kirschfink, et al.
Pageof 25

Showing results (121-130 of 243) with videos related to

Sort By:
Pageof 25
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2015
Diabetes-related end-stage renal disease in Austria 1965-2013Friedrich C Prischl, Martin Auinger, Marcus Säemann, et al.
Nephron. Experimental Nephrology|February 28, 2004
Role of thrombospondin-1 in the autologous phase of an accelerated model of anti-glomerular basement membrane glomerulonephritisKathrin Hochegger, Sara Knight, Christian Hugo, et al.
International Journal of Molecular Sciences|November 3, 2020
Empagliflozin Inhibits Basal and IL-1β-Mediated MCP-1/CCL2 and Endothelin-1 Expression in Human Proximal Tubular CellsMarkus Pirklbauer, Maximilian Bernd, Lisa Fuchs, et al.
International Journal of Molecular Sciences|July 2, 2021
Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney DiseaseJohannes Leierer, Paul Perco, Benedikt Hofer, et al.
European Journal of Clinical Investigation|December 20, 2024
Type 2 diabetes and chronic kidney disease as long-term predictors of cardiovascular events in patients with coronary artery diseaseLaura Schnetzer, Andreas Leiherer, Andreas Festa, et al.
Pediatric Nephrology (Berlin, Germany)|March 11, 2016
The nephrologist of tomorrow: towards a kidney-omic futureMina H Hanna, Alessandra Dalla Gassa, Gert Mayer, et al.
Diabetologia|April 20, 2019
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney diseaseHiddo J L Heerspink, Paul Perco, Skander Mulder, et al.
Immunology|January 25, 2007
Expression of granzyme A in human polymorphonuclear neutrophilsKathrin Hochegger, Philipp Eller, Julia M Huber, et al.
International Journal of Clinical and Experimental Pathology|September 10, 2011
The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomeru-lonephritisEmanuel Zitt, Kathrin Eller, Julia M Huber, et al.
Medicine|December 5, 2014
Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case reportAndreas Kronbichler, Renate Frank, Michael Kirschfink, et al.
Pageof 25